Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 35.873% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a Cc1cc(SCNC(=O)c2ccccc2)nc(C(C)C)n1
b Cc1cc(C)c(C(=O)COC(=O)c2cc([N+](=O)[O-])ccc2NCCO)cc1C
c CCOC(=O)CCc1c(C)c(C#N)c2nc3ccccc3n2c1-n1ccnc1
d Cn1cnnc1Sc1cc(N2CCN(S(=O)(=O)c3ccccc3)CC2)ccc1[N+](=O)[O-]
e Cc1ccc(-c2c(C#N)cnc3c(N=Nc4ccccc4Cl)c(N)nn23)cc1
Answer: a. Cc1cc(SCNC(=O)c2ccccc2)nc(C(C)C)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(SCNC(=O)c2ccccc2)nc(C(C)C)n1
Cc1cc(SCNC(=O)c2ccccc2)nc(C(C)C)n1
N-[(6-methyl-2-propan-2-ylpyrimidin-4-yl)sulfanylmethyl]benzamide